HSA — authorised 31 December 1990
- Marketing authorisation holder: FERA PHARMS
- Status: likely_approved
HSA authorised Dapiprazole Hydrochloride on 31 December 1990
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 31 December 1990.
FERA PHARMS holds the Singaporean marketing authorisation.